Otros idiomas EBOS Group Limited

Acciones

EBO

NZEBOE0001S6

Farmacéuticos

Precio de cierre New Zealand S.E. Otros sitios de cotización 13/06/2025			Variación 5 días	Varia. 1 de enero.
36,56 ^NZD	-0,65 %		-3,69 %	-1,32 %

03/06	EBOS afirma que AustralianSuper se convierte en accionista significativo	MT
29/05	Las acciones australianas se mantienen estables; Ebos anuncia que su principal accionista, Sybos, reducirá su participación	MT

Otros idiomas

EBOS says AustralianSuper Becomes Substantial Holder	03/06
Australian Shares Flat; Ebos Says Major Shareholder Sybos to Reduce Stake	29/05
ASX Preview: Australian Shares to Open Lower as US Fed Officials Back Cautious Rate Approach; Ebos' Major Shareholder to Cut Stake	29/05
Ebos Says Major Shareholder Sybos to Reduce Stake; Shares Tumble 7%	29/05
EBOS Group's Major Shareholder Sybos Reportedly Launches NZD 949 Million Selldown	28/05
LTR Pharma Makes SPONTAN Product Available Through Pharmacy Network, Shares Jump 38%	20/05
EBOS Raises AU$54 Million Via Retail Offer	12/05
New Zealand Shares Rise on US-China Trade Talks, EBOS Says Retail Offer Oversubscribed	12/05
Ebos Closes Up to AU$50 Million Retail Offer	07/05
New Zealand Shares Rise Despite Tariff-Induced Fall in Global Indexes, Scales Ups Stake in Unit	16/04
EBOS Group Opens Up to AU$50 Million Retail Offer	16/04
NZX Biggest Losers	11/04
Ebos Group Raises AU$200 Million via Placement; Retail Offer to Open on April 16	11/04
Fonterra Co-operative Names Chair of Mainland Group Amid Potential Divestment of Global Consumer Business	31/03
Ebos Denies Speculation Over Real Pet Food Acquisition	17/03
EBOS Group Limited Reports Earnings Results for the Half Year Ended December 31, 2024	19/02
New Zealand Shares Extend Muted Session After Rate Cut; Fletcher Building Jumps 5% as Loss Narrows in Fiscal H1	19/02
EBOS : 2025 Half Year Results Investor Presentation	19/02
ASX Midday Sector Update: Healthcare Stocks Rise, Financials Stocks Plunge	19/02
EBOS Group Appoints Adam Hall as CEO	19/02
EBOS Group Posts Lower Fiscal H1 Earnings as Revenue Drops	19/02
Ebos Group Posts Fiscal H1 Underlying EPS of AU$0.675, Attributable EPS of AU$0.569, Revenue of AU$5.99 Billion	18/02
EBOS : 2025 Interim Report	18/02
EBOS Group Limited Announces CEO Changes	18/02
EBOS Group Limited Declares an Interim Dividend for the First Half Ended December 31, 2024, Payable on 21 March 2025	18/02

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripciones Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas EBOS Group Limited

Acciones

EBO

NZEBOE0001S6

Farmacéuticos

Otros idiomas

Filtros